Acon Pharmaceuticals

  • ACON Pharmaceuticals
About Acon Pharmaceuticals

ACON Pharmaceuticals (ACON Pharma) is a specialty pharmaceutical company and focuses on siRNA and mRNA LNP, NDA, BLA, 505(b)(2), and complex ANDA drug product development with its captive drug delivery system technology platforms. Acon Pharma provides service to its customers to accelerate their IND and NDA product development by offering its proprietary drug delivery platforms, pre-formulation, formulation, process development, and manufacturing of different types of dosage forms and drug delivery systems.

  • Country/Region:
    United States
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Biopharmaceutical company
CMO/CDMO
Consultancy
Contract Research Organisation (CRO)
Contract Service
Drug delivery device Supplier/Manufacturer
Generics/Biosimilars Manufacturer
Pharmaceutical company
Start-up
Primary activities
Analytical Services
Biopharmaceutical
Chemical Development
Contract Manufacturer
Contract Research Organisation
Finished Formulation products Distributor/Buyer
Laboratory Services
Laboratory, Analytical, Biotechnology Equipment
OTC
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Technology
Contact info
  • 2557 Route 130, Ste 3,,, NJ, 8512, Cranbury, United States
Meet us at

CPHI Americas 2026

Pennsylvania Convention Center, Philadelphia
2 Jun 2026 - 4 June 2026

Products from Acon Pharmaceuticals (5)

Acon Pharmaceuticals Resources (1)

  • News siRNA and mRNA LNP

    ACON Pharma provides development of mRNA, siRNA lipid nanoparticle (LNP) products as therapeutics or vaccine.